Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.59 Insider Own36.14% Shs Outstand8.10M Perf Week-4.94%
Market Cap20.30M Forward P/E- EPS next Y-1.81 Insider Trans-0.09% Shs Float5.18M Perf Month-10.55%
Income-37.13M PEG- EPS next Q-1.21 Inst Own26.01% Short Float5.79% Perf Quarter-16.67%
Sales1.52M P/S13.36 EPS this Y23.83% Inst Trans7.76% Short Ratio9.89 Perf Half Y-18.03%
Book/sh2.15 P/B1.16 EPS next Y43.09% ROA-80.89% Short Interest0.30M Perf Year-30.07%
Cash/sh2.85 P/C0.88 EPS next 5Y15.20% ROE-106.15% 52W Range2.01 - 4.55 Perf YTD-21.38%
Dividend Est.- P/FCF- EPS past 5Y20.27% ROI-156.90% 52W High-45.05% Beta0.67
Dividend TTM- Quick Ratio6.24 Sales past 5Y106.75% Gross Margin97.57% 52W Low24.38% ATR (14)0.22
Dividend Ex-Date- Current Ratio6.24 EPS Y/Y TTM-24.35% Oper. Margin-2586.30% RSI (14)42.08 Volatility7.82% 8.57%
Employees33 Debt/Eq0.37 Sales Y/Y TTM-27.48% Profit Margin-2434.69% Recom1.00 Target Price22.50
Option/ShortNo / Yes LT Debt/Eq0.36 EPS Q/Q-44.50% Payout- Rel Volume0.53 Prev Close2.57
Sales Surprise-45.00% EPS Surprise-13.56% Sales Q/Q-76.12% EarningsMay 15 BMO Avg Volume30.35K Price2.50
SMA20-10.19% SMA50-9.16% SMA200-18.57% Trades Volume15,943 Change-2.72%
Date Action Analyst Rating Change Price Target Change
Mar-11-21Upgrade Stifel Hold → Buy $4 → $24
Dec-03-20Initiated Cantor Fitzgerald Buy $32
Aug-26-20Initiated Piper Sandler Overweight $26
Aug-17-20Resumed ROTH Capital Buy $51
Aug-04-20Initiated H.C. Wainwright Buy $33
May-20-24 04:05PM
May-16-24 03:02AM
May-14-24 10:53PM
May-09-24 02:51PM
04:05PM Loading…
Apr-18-24 04:05PM
Mar-20-24 08:00AM
Mar-08-24 02:06PM
Mar-07-24 09:54PM
Feb-26-24 09:00AM
Feb-05-24 04:05PM
Jan-04-24 04:05PM
Nov-21-23 04:15PM
Nov-20-23 04:05PM
04:35PM Loading…
Nov-07-23 04:35PM
Sep-26-23 09:00AM
Sep-14-23 08:00AM
Sep-07-23 04:34PM
Aug-22-23 09:00AM
Aug-09-23 04:01PM
Jul-26-23 09:00AM
Jul-12-23 08:00AM
Jun-28-23 04:01PM
Jun-21-23 09:00AM
May-31-23 08:00AM
May-25-23 08:00AM
May-22-23 09:00AM
May-08-23 08:00AM
04:05PM Loading…
May-03-23 04:05PM
Apr-27-23 09:00AM
Apr-19-23 09:00AM
Mar-09-23 04:05PM
Mar-05-23 02:00PM
Mar-01-23 04:05PM
Feb-28-23 04:05PM
Feb-15-23 04:05PM
Jan-03-23 09:00AM
Dec-12-22 07:30AM
Nov-29-22 04:05PM
Nov-22-22 04:05PM
Nov-14-22 06:10AM
Sep-26-22 04:05PM
Aug-31-22 09:00AM
Aug-16-22 07:30AM
Aug-09-22 04:01PM
Jul-27-22 04:05PM
Jul-24-22 08:27AM
Jul-20-22 08:32PM
May-16-22 04:05PM
May-10-22 04:01PM
May-06-22 10:25AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Apr-11-22 08:30AM
Mar-23-22 04:05PM
Mar-10-22 04:01PM
Feb-23-22 09:00AM
Feb-14-22 12:05PM
Jan-05-22 09:00AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-24-21 10:00AM
Nov-15-21 11:14AM
Nov-10-21 05:06PM
Nov-08-21 10:42AM
Nov-03-21 04:01PM
Oct-21-21 04:05PM
Sep-02-21 08:00AM
Aug-16-21 09:58AM
Aug-05-21 08:00AM
Aug-03-21 08:00AM
Aug-02-21 08:00AM
Jul-26-21 04:18PM
Jul-22-21 08:00AM
Jul-20-21 04:01PM
Jun-28-21 08:00AM
May-19-21 09:00AM
May-13-21 09:00AM
May-05-21 04:01PM
Apr-28-21 09:00AM
Apr-27-21 08:00AM
Apr-20-21 04:05PM
Apr-14-21 04:05PM
Mar-20-21 11:00AM
Mar-11-21 04:05PM
Mar-09-21 04:05PM
Mar-04-21 09:00AM
Mar-02-21 04:05PM
Feb-22-21 04:15PM
Feb-16-21 04:01PM
Dec-18-20 09:00AM
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKew John C.Chief Scientific OfficerApr 03 '24Sale2.772,2146,14417,153Apr 03 05:10 PM
McKew John C.Chief Scientific OfficerFeb 06 '24Sale3.034381,32818,403Feb 07 05:22 PM
McKew John C.Chief Scientific OfficerAug 02 '23Sale3.213,40710,91918,707Aug 03 04:58 PM